July 16, 2012 — LipoScience Inc., an in vitro diagnostic company developing clinical diagnostic tests using nuclear magnetic resonance (NMR) technology, announced publication of the findings of a clinical study in the current issue of the Journal of the American College of Cardiology indicating that high density lipoprotein (HDL) particle number has a stronger, more independent association with coronary heart disease and carotid atherosclerosis than HDL cholesterol (HDL-C).

 

July 16, 2012 — Medical imaging has always been an important part of clinical trials.  Echocardiography, which uses sound waves to create moving real-time images of cardiac structure and function, provides an excellent noninvasive method to evaluate the impact of therapeutics on cardiac morphology.

July 16, 2012 — The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $4.78 million grant to researchers at Cleveland Clinic’s Lerner Research Institute to use metabolomics — a new approach that focuses on the small-molecule byproducts of metabolism —  for discovery of novel pathways linked to the development of cardiovascular diseases.

 

July 16, 2012 — Cardiosolutions Inc., an early-stage company focused on the development of an innovative percutaneous system to treat patients with moderate to severe mitral valve regurgitation, today announced it has received a minority investment from Sorin Group. Sorin is a global medical device company and develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. 

 

July 16, 2012 — The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of Alere Triage products. Identified lots may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results.


Echocardiography is a natural application for telemedicine, as handheld ultrasound devices and cloud-based transmission solutions make it possible to perform a test at a remote location and have consultation, in real time, by an expert thousands of miles away. Telemedicine can eliminate the need for travel, reduce wait time for test results, and is cost effective.

 

July 13, 2012 — GE Healthcare and VPDiagnostics Inc. jointly announced today their co-marketing agreement for the VPDiagnostics’ MRI-PlaqueView software for carotid artery atherosclerosis analysis.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now